Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (LKFT)

Q: What does CUSIP 36315X101 represent in this 13F holders report?

CUSIP 36315X101 is the security identifier for LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") used to aggregate holder disclosures.

Q: How many institutions held LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") in Q2 2025?

85 institutional investors reported LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 36315X101

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Ordinary shares, no nominal value per share (the "Ordinary Shares")
Total 13F shares: 31,697,765
Total 13F value: $887,221,465
Share change: +628,480
Put/Call ratio: 59%
SEC-reported price per share: $27.99
Number of holders: 85
Value change: +$28,214,019
Number of buys: 47
Number of sells: 41
Shares outstanding: 65,567,327

Security key

36315X101

Report period

Q2 2025

Institutions

Top holders

LKFT full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Lakefront Biotherapeutics NV SEC filings Lakefront Biotherapeutics NV company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 36315X101

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GILEAD SCIENCES, INC.

Disclosed value leader

GILEAD SCIENCES, INC.

Comparable rows

15/15

Latest evidence

31 Mar 2025

13D/G 13F Lead comparable stake: 30% 13D/G row: GILEAD SCIENCES, INC. Showing 1-6 of 15 holder rows.

Quick read

GILEAD SCIENCES, INC. leads the comparable SEC ownership view at 30%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GILEAD SCIENCES, INC.'s linked filing trail.

Comparable ownership Top 5

GILEAD SCIENCES, INC. 30%

TANG CAPITAL MANAGEMENT LLC 6%

FMR LLC 2.4%

BVF INC/IL 2.2%

Prosight Management, LP 2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GILEAD SCIENCES, INC.	13D/G 13F Company 13D/G 13F	30%	$555,786,955 20,981,010 shares	$0	07 Jan 2025
TANG CAPITAL MANAGEMENT LLC	13F Company 13F	6%	$99,520,341 3,961,797 shares	—	31 Mar 2025
FMR LLC	13F Company 13F	2.4%	$39,108,225 1,556,856 shares	—	31 Mar 2025
BVF INC/IL	13F Company 13F	2.2%	$36,535,081 1,454,422 shares	—	31 Mar 2025
Prosight Management, LP	13F Company 13F	2%	$33,030,238 1,314,898 shares	—	31 Mar 2025
Deep Track Capital, LP	13F Company 13F	1.1%	$18,615,628 741,068 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

31,697,765

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend